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To investigate trends in population incidence of HIV positive hospital admission and risk of 
in-hospital death among adults living with HIV between 2012 and 2019 in Blantyre, Malawi. 
Design 
Population cohort study using an existing electronic health information system (‘SPINE’) at 
Queen Elizabeth Central Hospital and Blantyre census data. 
Methods 
We used multiple imputation and negative binomial regression to estimate population age- 
and sex-specific admission rates over time. We used a log-binomial model to investigate 
trends in risk of in-hospital death.  
Results 
Of 32,814 adult medical admissions during Q4.2012-Q3.2019, HIV status was recorded for 
75.6%. HIV-positive admissions decreased substantially between 2012 and 2019. After 
imputation for missing data, HIV positive admissions were highest in Q3.2013 (173 per 
100,000 adult Blantyre residents) and lowest in Q3.2019 (53 per 100,000 residents). An 
estimated 10,818 fewer than expected people living with HIV (PLHIV) (95%CI 10,068-
11,568) were admitted during 2012-2019 compared to the counterfactual situation where 
admission rates stayed the same throughout this period. Absolute reductions were greatest for 
women aged 25-34 years (2,264 fewer HIV-positive admissions, 95%CI 2,002-2,526). In-
hospital mortality for PLHIV was 23.5%, with no significant change over time in any age-sex 
group, and no association with ART use at admission. 
 
Conclusions 
Rates of admission for adult PLHIV decreased substantially, likely due to large increases in 
community provision of HIV diagnosis, treatment and care. However, HIV-positive in-
hospital deaths remain unacceptably high, despite improvements in ART coverage. A 
concerted research and implementation agenda is urgently needed to reduce inpatient deaths 
among PLHIV. 




The Joint United Nations Programme on HIV/AIDS (UNAIDS), national country HIV 
programmes and many other actors in the HIV community share a common goal to end AIDS 
as a public health problem by 2030. In sub-Saharan Africa, great progress has been made 
towards goals of achieving 95% of people living with HIV knowing their status, 95% of 
those who know their status to be taking antiretrovial therapy (ART), and 95% of those of 
those taking ART to have undetectable HIV viral loads. Malawi is one of countries worst 
affected by the HIV epidemic, with estimated adult HIV prevalence in 2019 of 8.9% 
nationwide and 17.7% in Blantyre City.(1) In the past two decades the Malawi national HIV 
programme has made excellent progress in providing HIV testing, ART and other HIV care 
services; in 2019, 90% of all PLHIV in Malawi knew their HIV status, 88% of those who 
knew their status were taking ART and 92% of those on ART were virally suppressed.(2) 
Despite increasing population ART coverage, the number of PLHIV becoming unwell and 
attending hospital has remained high in several countries in Southern and Eastern Africa. For 
example, 60% of hospital admissions to a general hospital in South Africa were related to 
HIV in 2012-13, despite widespread ART availability in the community at that time.(3) 
Similarly, 50% and 42% of admissions to hospital in Lilongwe, Malawi between 2011 and 
2012 and Kweneng East District, Botswana between 2015 and 2016, respectively, were 
related to HIV.(4,5) Another study found that 83% and 97% of PLHIV admitted to hospitals 
in Kenya and DRC respectively had advanced immunosuppression (CD4 <200 cells/mm3).(6) 
In general, hospital epidemiological data related to HIV in Southern and Eastern Africa is 
sparse. In Johannesburg, South Africa, 39% of people initiating ART in 2017 had CD4 <200, 
indicating that advanced HIV remains a persistent challenge.(7–9)  
We used routine hospital data and city census data to investigate changes in HIV-positive 
hospital admissions to adult medical wards over time in Blantyre, Malawi, where there is 
only one public hospital serving the population, acting as both District General Hospital and a 
tertiary referral hospital. The primary objective was to assess time trends in the incidence (i.e. 
number of hospital admissions per 100,000 population) of HIV-positive hospital admission 
for Blantyre residents between 2012 and 2019. The secondary objective was to investigate 
 
whether hospital admission outcomes (died vs. discharged from hospital alive) for people 
living with HIV (PLHIV) have changed over time. 
Methods 
Setting 
Blantyre District contains the second largest city in Malawi (Blantyre City) and it’s 
surrounding periurban/rural area. At the 2018 census, Blantyre District had a population of 
approximately 1.2 million people with a median age 17 years.(10) One main government 
hospital (Queen Elizabeth Central Hospital, QECH) provides free secondary and tertiary care 
to the population of Blantyre, including inpatient medical care. There are some smaller 
private (including private-not-for-profit) hospitals accessed by a small sub-set of the 
population who can afford the fees, but the vast majority of people living in Blantyre rely on 
QECH exclusively for inpatient care. QECH provides a range of general medical services, 
HIV testing (provider-initiated testing and counselling [PITC]) and ART.  QECH has 120 
general adult medical beds and this capacity hasn’t substantially changed between 2012 and 
present. 
Population and data sources 
Since late 2009 adult medical admissions to QECH have been recorded in in an electronic 
surveillance system (Surveillance Programme of IN-patients and Epidemiology [SPINE]) by 
data clerks working on both of the medical admissions wards.(11) For all patients admitted to 
the wards, data clerks recorded: sex, age, neighbourhood of residence, date of admission, 
HIV status, ART status and outcome (discharge from hospital alive vs. died prior to 
discharge). Individual patients are not linked over time, and results of CD4 cell counts or 
HIV viral load tests are not recorded. ART status was ascertained from medical notes or a 
patient-held record (“health passport”) during admission. Quality is assured by reconciling 
admissions with government paper ledgers, nurses’ paper records and data clerks physically 
walking around bed spaces each morning. There was some interruption to SPINE data 
collection in 2011–2012, so we included medical admissions recorded by SPINE from 
October 2012 to September 2019. We removed duplicate records, records for people under 15 
years old and records for inpatients who reported residing outside of Blantyre. We assumed 
that those with missing location data lived in Blantyre. 
The government of Malawi conducted population censuses in 2008 and 2018. Mid-quarter 
population estimates for Blantyre (combining “Blantyre urban” and “Blantyre rural” areas) 
for each quarter between October 2012 and September 2019 were calculated by linear 
interpolation and extrapolation, by 10-year age group and sex. 
Statistical analysis 
Characteristics of patients admitted to QECH medical wards were summarised using 
percentages, and compared to interpolated Blantyre census data. Where data on HIV status, 
 
ART and outcome were missing in SPINE, we used multiple imputation by chained 
equations (using the ‘mice’ package in R) with predictive mean matching to impute missing 
data.(12) Variables used for imputation were HIV status, age group, quarter-year, sex and 
outcome. Missing ART status for the small number of people who reported being HIV 
positive was also imputed based on the above variables. Since ART status missingness is 
conditional on HIV status missingness, we did not impute ART status for people who had 
missing or unknown HIV status in SPINE. For the secondary outcome assessing assosciations 
with in-hospital death, we assumed that everyone who was HIV positive (based in 
imputation) but had an unknown or missing HIV status in SPINE was not taking ART – this 
was not relevant for the primary outcome of incidence of admission. We imputed 25 datasets 
(reflecting the ~25% missingness of ART status), and combined model outputs across all 25 
datasets using Rubin’s rules.(13–15) Sensitivity analyses were performed by conducting 
complete case analysis; for HIV-related admission incidence analysis, complete case analysis 
is equivalent to assuming all participants with unknown HIV status were HIV-negative.  
We estimated the incidence of HIV-positive and HIV-negative admission to hospital among 
Blantyre residents per quarter-year between Q4.2012 and Q3.2019 overall, and separately for 
each age group-sex-quarter strata. To investigate trends in admission over time, we fitted a 
negative binomial regression model (because the data were overdispersed) with interactions 
between age group, sex and quarter, and a natural cubic spline term with three knots for 
annual quarter.  Age group and sex were included as interaction variables in the models a 
priori because there are sex and age-group specific differences in HIV incidence, prevalence, 
and access to testing and ART services. We performed sensitivity analyses using the Poisson 
and gamma response distributions, and separately without spline terms.  
To quantify the magnitude of change in admissions over the study period overall, and for 
each age group-sex strata, we calculated the expected number of admissions under the 
counterfactual condition where the incidence of HIV positive admission remained constant as 
the model predicted for Q4.2012 (ie. the first quarter of observation) over the entire study 
period, and subtracted from the model-predicted number of admissions. Confidence intervals 
were estimated using parametric bootstrap resampling. 
Temporal trends in the risk of inpatient death were analysed using a generalised linear model 
with log-binomial link function to approximate risk of death. Age group and sex were 
included as interaction variables a priori. We investigated whether adding ART use at 
admission (including ART used as an interaction variable with age, sex and quarter-year) 
improved model fit using Akaike information criteria. 
Ethical approval, funding and data sharing 
Use of anonymous electronic data (from SPINE project) was approved by QECH hospital 
research committee. Individual patient consent for anonymised secondary analysis was not 
sought.  
 
All code for analyses, Blantyre census dataset, datapoints from figures and a ‘synthetic’ (i.e. 
artificial data that mimics properties of real data) dataset for hospital admissions are available 
online at https://rachaelmburke.github.io/hivhospital/. Synthetic data was created using 
synthpop package.(16) Further details including how to access real data are included in data 
sharing statement. 
SPINE received funding from Wellcome Core Grant to the Malawi-Liverpool-Wellcome 
Trust (reference 206545). RMB, ELC and PM are funded by Wellcome (203905/Z/16/Z, 
200901/Z/16/Z, and 206575/Z/17/Z, respectively).  
Results 
During the 28 quarters between October 2012 and September 2019, there were 32,814 
medical admissions to QECH among adults (age ≥15 years) who resided in Blantyre (median 
quarterly admissions 154 per 100,000 people). There were a further 5,511 people admitted to 
QECH who reported residing outside of Blantyre, and their data were excluded from this 
analysis. Fifty percent (16,408) of these were known to be HIV-positive, and in 24% (7,996) 
of admissions, HIV status was unknown (Table 1). 
Incidence of HIV related admission 
The median number of known HIV-positive admissions (i.e. before imputation for missing 
HIV status) to QECH per quarter-year was 592 (80 per 100,000 Blantyre population). It was 
highest in Q3 2014 (767 known HIV-positive admissions, 110 per 100,000) and lowest in Q2 
2019 (343 known HIV-positive admissions, 44 per 100,000) in Q2 2019. In contrast, known 
HIV-negative admissions were at their lowest towards the start of the study period, with 160 
admissions (23 per 100,000 population) in Q3 2013 and highest in Q3.2019 with 482 
admissions (61 per 100,000). The number of admissions with unknown or missing HIV status 
decreased throughout the study period, with a 695 admissions with HIV status missing or 
unknown in Q3 2017 (102 per 100,000) and 104 HIV unknown admissions in Q1 2017 (13 
per 100,000). The proportion of people currently taking ART among known PLHIV admitted 
to hospital increased from 66% (363/550) in Q4 2012 to 94% in Q3 2019 (372/402); the 
denominator includes those who knew their HIV status prior to admission and those newly 
diagnosed in hospital, but not those who had missing or unknown HIV status recorded. 
Supplementary Figures 1A-C, http://links.lww.com/QAD/C230 show HIV status, absolute 
number and population incidence of admissions over time.  The adult Blantyre mid-year 
census population was 577,893 in 2008 and was 764,323 in 2018. The estimated population 
in February 2016 (i.e. the mid study period) was 722,377 (Supplementary Table 1B, 
http://links.lww.com/QAD/C230). 
Multiple imputation and modelling trends in incidence of HIV-related hospital admission 
After using multiple imputation to impute HIV status for the 24% (7,996/32,814) of people 
where it was unknown, estimated true HIV-positive admissions were highest in Q3 2013 with 
 
1169 admissions (173 per 100,000) and lowest in Q2 2019 with 417 admissions (53 per 
100,000). If we assume that all those with missing or unknown HIV status in SPINE but who 
were HIV positive based on imputation were not taking ART, then ART coverage increased 
from 48% in Q4 2012 to 76% in Q3 2019.   
Using regression modelling with parameters averaged across 25 multiply-imputed datasets, 
we estimate that the true number of HIV-positive hospital admissions between Q4 2012 and 
Q3 2019 (inclusive) was 21,170 (95% confidence interval [CI] 20,411–21,928). Between 
October 2012 and September 2019, the modelled trend of incidence of HIV-positive hospital 
admission in Blantyre decreased in all age and sex groups (Figure 2). In sensitivity analysis, 
this overall finding was robust to reclassification of missing HIV data (Table 2 and 
Supplementary Figures 2A and 2B, http://links.lww.com/QAD/C230), and to model 
specification (Supplementary Figures 3A-3D, http://links.lww.com/QAD/C230). 
If the age group- and sex-specific incidence of HIV related hospital admissions had stayed 
the same throughout the period October 2012–September 2019 as it was in Q4 2012, then we 
would have expected to see 31,988 (95% CI 31,229–32,746) HIV-positive admissions, taking 
into account the increasing population of Blantyre. Therefore, we estimate that there were 
10,818 (95% CI, 10,060–11,577) fewer HIV-positive admissions during this period than there 
would have been under counterfactual scenario where incidence of admission had remained 
constant during this period (Table 2). This is equivalent to 33.8% fewer HIV-positive 
admissions (95% CI 32.3% to 35.4%).  
The greatest reductions in absolute numbers of admissions compared to expected number of 
admissions had there been no change in population incidence of admission were in women 
aged 25–34 years old and men aged 35–44 years old. The smallest magnitude of absolute 
decline in admissions were in men aged 55–64 years old and men age 65+ (Figure 2 and 
Supplementary Table 2, http://links.lww.com/QAD/C230).  
These estimates were robust to reclassification of missing HIV status. If all admissions with 
missing HIV status were considered to be HIV-negative we estimate there would have been 
3,854 (95% CI: 3,453 to 4,255) fewer HIV-positive admissions (equivalent to a 19.0% 
decrease), and if all admissions with unknown HIV status were considered HIV-positive, 
there would have been 13,865 (95% CI: 13,050 to 14,681) fewer admissions (equivalent to a 
36.2% decrease). In the sensitivity analysis scenario where all patients with missing HIV 
status were classified as HIV-negative, while overall HIV-positive admissions decreased, but 
there was no decrease in admissions among women aged 45 years or older, nor among men 
aged 65 years or older (Supplementary Table 2, http://links.lww.com/QAD/C230 and 
Supplementary Figure 2B, http://links.lww.com/QAD/C230).  
During this period, the incidence of HIV negative hospital admissions stayed the same or 
increased in all age and sex groups (Figure 2) and increased substantially among those 65 
years or older. 
 
95% confidence intervals estimated through parametric bootstrapping of 25 multiply-imputed 
datasets 
Outcomes for PLHIV admitted to QECH 
Overall, 18.5% (6,071/32,814) of adults admitted to QECH died during their admission, and 
a further 8% (2,687 / 32,814) had unknown outcome or missing outcome data. After multiple 
imputation, we estimate the proportion of adult medical inpatients who died to be 20.3% 
overall and 23.5% among PLHIV (Table 3). Supplementary Table 3A and 3B show outcomes 
by age group and sex, http://links.lww.com/QAD/C230. 
Risk of inpatient death did not change over the study period overall, or within any age-sex 
subgroups (Figure 2 and Supplementary Table 4, http://links.lww.com/QAD/C230). This 
finding was robust to sensitivity analyses for misclassification of HIV status and outcome 
(complete case analysis - Supplementary Figure 4, http://links.lww.com/QAD/C230). 
Reported ART use at admission did not affect the risk of in-hospital death and did not 
improve the model fit (Supplementary Figure 5, http://links.lww.com/QAD/C230); Akaike 
information criteria statistics were higher in models that included ART as a covariate in all 25 
imputed datasets. Risk of death was higher for people living with HIV than people without 
HIV in all age and sex groups (Table 3, Supplementary Table 3, 
http://links.lww.com/QAD/C230, and Supplementary Figure 6, 
http://links.lww.com/QAD/C230). 
Discussion 
We used electronic inpatient records and national census data to show that between 2012 and 
2019, per capita rates of HIV-positive medical admissions in Blantyre, Malawi decreased 
substantially. There were an estimated 10,818 (95% CI: 10,068 to 11,568) fewer HIV-
positive admissions to the single public hospital than would have been expected if admission 
rates had been unchanged from the last quarter of 2012. These data were adjusted for 
population growth, and excluded tertiary admissions referred from districts outside of 
Blantyre. The likely driver was ART scale-up, with substantial increases in community ART 
coverage during this time, consistent with the observed increase in the proportion of HIV-
positive patients already on ART at the time of admission. Once admitted, however, mortality 
remained extremely high with 23.5% of PLHIV dying before discharge, no obvious 
improvements over time, and no benefits from being on ART at the time of admission. High 
in-patient mortality following medical admission in Africa is a critical issue that needs to be 
investigated and addressed urgently. 
The substantial reduction in admission rates is an encouraging finding, and is congruent with 
other data which indicate that the proportion of people living with HIV in Blantyre who know 
their status, are on treatment, and are virally supressed and therefore not experiencing 
medical complications has increased considerably between 2012 and 2019,(2) a tremendous 
testament to the Malawian National HIV Programme. Alternative explanations for our 
 
findings are less likely. Queen Elizabeth Central Hospital is the single government hospital 
for the city, and care has remained free of charge and available to the population with no 
substantial changes or prolonged disruption to services during this time. Of note, this analysis 
ends in September 2019, before any COVID-19 related disruption. Incidence of HIV-
negative hospital admissions stayed the same or increased in every age and sex group during 
this time, consistent with investments in health system strengthening and indicating that the 
decline in HIV positive admissions is not a data capture issue.   
To put these results into context; estimated national adult HIV prevalence in Malawi was 
relatively static between 2012 and 2019, although AIDS deaths and new HIV infections fell, 
concurrent with rising coverage of ART.(17) There are limited subnational HIV estimates for 
Blantyre derived from NAOMI/Spectrum models, with estimates available for March 2016 
and December 2019 only.(18,19) Similar to national estimates, Blantyre adult HIV 
prevalence was largely unchanged at 17.0% in March 2016 and 16.7% in December 2019.  
Blantyre ART coverage increased, from 60.1% in March 2016 to 73.6% in December 2019; 
which is similar to the observed ART coverage in our analysis. Nationally, the peak of AIDS 
related deaths in Malawi was in 2004 with 71,000 deaths, several years before the SPINE 
database was commenced.  Between 2012 and 2019 (i.e. the dates of this analysis) national 
HIV related deaths declined from 24,000 annually to 13,000, with steeper declines at the start 
of this time period. There are no subnational estimates for deaths. As an approximate 
estimate — assuming that the proportion of HIV related deaths in Blantyre compared to the 
rest of Malawi is the same as the proportion of people living with HIV in Blantyre compared 
to the rest of Malawi — in 2018, between one quarter and one third of all Blantyre HIV 
related deaths occurred in QECH and were captured in this analysis.  Our hospital 
observations are consistent with the modelled national and subnational trends; this analysis 
provides a further demonstration from empiric longitutinal data (rather than modelled data) of 
the impact of ART on the HIV epidemic in Malawi. 
Once admitted to medical wards the risk of in-hospital death remained high and unchanged 
throughout the seven-year study period, being 23.5% for HIV-positive medial inpatients and 
14.5% for HIV-negative inpatients, once missing HIV status and outcomes were imputed.  
Although ART coverage among PLHIV admitted to hospital increased substantially between 
2012-19 (commensurate with increasing population ART coverage), ART use at admission 
did not alter risk of death. The impact of virological failure in this cohort can only be 
inferred, as HIV viral load measurement on admission is not currently supported by the 
routine medical services, and data on HIV viral loads are not routinely captured. Studies that 
have measured HIV virologic failure among people in hospital have shown similarly high 
mortality and high levels of proven HIV virologic failure among people admitted to hospital. 
In the STAMP trial in 2015 to 2017 in Zomba Central Hospital, Malawi (in a nearby district 
to Blantyre), 32% of all PLHIV admitted to hospital had confirmed HIV virologic failure and 
this was associated with increased risk of death.(20) Other African studies report a high 
prevalence of HIV virologic failure among PLHIV admitted to hospital; 63% and 62% in 
Kenya and Democratic Republic of Congo, respectively.(6) In a predictive model developed 
using STAMP data and validated on cohorts from another multi-centre trial and a cohort in 
 
Kenya, use of ART at admission to hospital was associated with increased risk of death by 
two months from admission.(21) In the present analysis, use of ART made no difference to 
risk of in-hospital death. 
At the start of the study period, slightly less than half of all people with HIV were taking 
ART. It is possible that, for those that survived the acute illness that precipitated admission, 
effective ART could be started and outcomes may be relatively favourable. By the end of the 
study period three quarters of HIV positive peole admitted to hospital were taking ART. If a 
substantial proportion of those on ART had HIV virologic failure and were not switched to 
effective ART, then they may be discharged with their acute illness treated, but the 
underlying immunosuppression that precipitated the illness unresolved. At present, WHO 
guidelines for managing confirmed or suspected HIV virologic failure do not distinguish 
between stable ambulatory outpatients and unwell patients admitted to hospital, and 
recommend enhanced adherence counselling following identification of an elevated HIV 
viral load.(22) There are scant data to address this issue or provide guidance as which groups 
of people require urgent ART switch and in which groups of people adherence counselling 
and repeat viral load may be appropriate. 
In a meta-analysis of PLHIV admitted to hospital, AIDS-related conditions (including 
tuberculosis and cryptococcal meningitis) and severe bacterial infections were the most 
common causes of admission and death,(23) consistent with previous data from QECH about 
cause of admission,(11) and suggesting that for most people living with HIV their HIV status 
is not incidental to the reason for hospital admission. Two trials have shown that urine-based 
TB diagnostics reduce deaths of PLHIV in hospital,(20,24) and several trials have shown 
effectiveness of newer antifungal treatments for cryptococcal meningitis.(25,26) However, 
there are no trials of pragmatic management protocols (which might include a package of 
diagnostics), or of interventions to optimise management of virological failure among people 
in hospital. In the era of universal ART coverage, PLHIV admitted to hospital should be 
managed with great urgency, given their high risk of imminent death, and we urge more trials 
to produce evidence-based pragmatic management protocols similar to those recently 
developed for patients with low CD4 counts.(27,28) 
There are some limitations to this work. We do not have information on cause of admission 
or cause of death for those who died. Similarly, we do not have information on HIV viral 
loads or CD4 counts, to be able to measure prevalence of advanced HIV or HIV virologic 
failure directly. There was no follow up beyond length of hospital stay to ascertain mortality 
in the immediate period after admission. Malawi has very recently switched first-line ART to 
a dolutegravir-based regimen, away from reliance on non-nucleoside reverse transciptase 
inhibitors (NNRTIs), including switching those who are stable on NNTRI-containing ART 
regimens;  the switch occurred in 2019, but this is too early to observe if this will have causes 
any change in HIV related hospital admissions.  QECH has a large outpatient ART service, 
so it is possible that people who were taking ART were more likely than those not on ART to 
be admitted to hospital (either due to emergency referral from ART clinic or from being 
familiar with services available at the hospital). This might mean that the proportion of 
 
inpatients taking ART is higher than the proportion of all people who are sick (but don’t 
access QECH hospital care) who are taking ART.  
In conclusion, the incidence of HIV-positive hospital admission in Blantyre has substantially 
reduced in the seven years between Q4.2012 to Q3.2019, in keeping with impressive gains in 
coverage of HIV testing, treatment and care in Malawi during this period. However, PLHIV 
who were admitted to hospital continued to experience extremely high in-hospital mortality 
that did not change throughout this period. This suggests that advanced HIV and HIV-related 
complications remain persistent clinical and public health challenges, even as large 
improvements are made in providing HIV testing and care services to the majority of 
community members in Malawi. Interventions to reduce deaths in PLHIV following 
admission to hospital, including prompt management of HIV virologic failure in unwell and 
unstable patients, are an urgent research priority. 
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Figure 1  Population incidence of hospital admission to medical wards QECH by HIV status 




Figure 2 Risk of inpatient death among PLHIV if admitted to Queen Elizabeth Central 





Table 1: Characteristics of adult medical admissions to Queen Elizabeth Central Hospital, 
Malawi, Q4 2012 – Q3 2019, and population demographics of Blantyre in Feb 2016 
(midpoint Q3 2012 – Q3 2019) 
Adult medical 
admissions Oct 2012 to 
Sept 2019 (N=32,814) 
Blantyre population 
estimates Feb 2016 
(N=722,377) 
Age (years)  
   15-24 4,808 (14.7%) 270,260 (37.4%) 
   25-34 8,404 (25.6%) 197,589 (27.4%) 
   35-44 8,161 (24.9%) 131,376 (18.2%) 
   45-54 4,074 (12.4%) 60,267 (8.3%) 
   55-64 2,968 (9.0%) 32,416 (4.5%) 
   65+ 4,399 (13.4%) 30,469 (4.2%) 
Sex  
   Females 16,618 (50.6%) 361,988 (50.1%) 
   Males 16,196 (49.4%) 360,389 (49.9%) 
HIV status  
   Negative 8,410 (25.6%)  
   Positive 16,408 (50.0%)  
   Missing or unknown 7,996 (24.4%)  
ART status (HIV positive 
only)  
 
   Currently taking ART 13,074 (79.7%)  
   Not currently taking ART 3,050 (18.6%)  
   Missing or unknown 284 (1.7%)  
Outcome from hospital 
admission  
 
   Alive 24,056 (73.3%)  
   Dead 6,071 (18.5%)  




Table 2: Estimates of magnitude of reduction of HIV-related admissions 
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(A-B / A) * 
HIV status imputed 
when missing 
31,988  










All HIV unknown / 
missing positive 
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All HIV unknown / 
missing negative 
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Data with imputation (mean of 
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HIV positive, not on ART 
2482 
(79.5%) 
640 (20.5%) - 
3122 
(100%) 
HIV positive, on ART 
10272 
(77.3%) 
3014 
(22.7%) 
- 
13286 
(100%) 
TOTAL 
26184 
(79.8%) 
6630 
(20.2%) 
- 
32814 
(100%) 
 
